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Abstract: Surgical limitations require alternative methods of repairing and replacing diseased and damaged tissue. Re-
generative medicine is a growing area of research with engineered tissues already being used successfully in patients. 
However, the demand for such tissues greatly outweighs the supply and a fast and accurate method of production is still 
required.  
3D bioprinting offers precision control as well as the ability to incorporate biological cues and cells directly into the 
material as it is being fabricated. Having precise control over scaffold morphology and chemistry is a significant step 
towards controlling cellular behaviour, particularly where undifferentiated cells, i.e., stem cells, are used. This level of 
control in the early stages of tissue development is crucial in building more complex systems that morphologically and 
functionally mimic in vivo tissue. 
Here we review 3D printing hydrogel materials for tissue engineering purposes and the incorporation of cells within 
them. Hydrogels are ideal materials for cell culture. They are structurally similar to native extracellular matrix, have a 
high nutrient retention capacity, allow cells to migrate and can be formed under mild conditions. The techniques used to 
produce these materials, as well as their benefits and limitations, are outlined. 
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1. Introduction 
hilst 2D printing has had a big influence on 
everyday living, the advent of additive 
processing technology in 1986[1] has seen 
an explosion in innovative ways of producing 3D 
structures, such as electronic devices[2], aircraft parts[3], 
medical devices[4] and tissue mimics[5–7]. For clinical 
applications, early designs based on creating sacrifi-
cial moulds as templates for the biomaterials[8] were 
quickly superseded by aqueous systems that could 
directly print biological materials[9−11]. Today, the fo-
cus is no longer just on providing a suitable  
platform for cell growth but combining engineering, 
materials science and cell biology to create a bespoke 
material of specific dimensions. That material must 
then integrate well with the patient’s healthy tissue 
and restore functionality to an acceptable level. In the 
pursuit of developing materials that meet such criteria, 
manufacturing techniques have also become more 
complex.  
3D bioprinting is the spatial control of the original 
scaffold preparation techniques with integration of 
chemical cues and living cells[12]. Printing sensitive 
biological materials presents new challenges, such as 
maintaining cell viability throughout the manufactur-
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ing process and preventing denaturation of proteins.  
In this review we introduce some of the materials 
used for bioprinting, how stem cells are currently in-
corporated into the materials and the advantages and 
limitations of the techniques used to achieve this. Here 
the focus is to review 3D bioprinting techniques cur-
rently employed to create implantable tissue. However, 
the same techniques may also be employed to create 
models for studying 3D cell behaviour, diseases and 
modes of repair.  
2. Techniques for 3D Bioprinting 
The main approaches to 3D bioprinting are: biomimi-
cry (taking inspiration from nature to develop novel 
materials), autonomous self-assembly (using cellular 
organisation to guide the development of bioprinted 
tissues) and mini-tissue building blocks (identifying 
and recreating the building blocks of tissues to pro-
duce complex systems)[13]. For any one of these strat-
egies, there are a number of techniques that can be 
employed for their fabrication. 
2.1 Inkjet Bioprinting 
Based on 2D ink-printing technology, inkjet printing is 
still the most popular printing method for 3D biologi-
cal tissues analogues. The first modifications of the 
technology replaced the ink reservoir with bioink and 
the paper-feed tray with an x-y-z controllable stage[14]. 
Inkjet printers use thermal or acoustic methods to de-
liver controlled volumes of the bioink to previously 
defined locations[15] and build the structure layer-by- 
layer. Thermal methods generate heat at the print head 
which forces ink out of the nozzle through pressure 
pulses. Although temperatures can reach 200–300°C 
during thermal inkjet printing, this lasts a few micro-
seconds, resulting in an overall temperature rise of 
4–10°C for aqueous systems, which has been shown 
not to have a detrimental effect on cell viability[16]. 
This method of printing is fast, cheap and readily 
available. However, although temperature effects on 
cells has been shown to be minimal, other factors such 
as print-head clogging, mechanical stress and unrelia-
bility in bioink dispensing, present the biggest disad-
vantages.  
Acoustic inkjet printing technology is based on ge-
nerating pressure in the nozzle by applying a voltage 
to a piezoelectric crystal which changes the crystal’s 
conformation. Controlling this process precisely al-
lows the bioink to be deposited as droplets[17]. A mod-
ification of this process uses ultrasound to create an 
acoustic radiation field and form droplets from an 
air-liquid interface. Control of droplet size and rate of 
deposition comes from ultrasound pulse, duration and 
amplitude[18]. The acoustic methods can be modified 
so that they are not reliant on nozzles[19]. This reduces 
the risk of clogging and shear stress on cells. There 
are also no changes in temperature during droplet 
formation. However, there is a risk of causing cell 
lysis and membrane damage from the frequencies 
used to change the piezoelectric crystal shape.  
One of the main drawbacks of using either thermal 
or piezoelectric-based inkjet printing methods is that 
only liquids with low viscosities are easily printable. 
This introduces further problems in creating a solid 
structure once the bioink has been deposited onto the 
stage[20]. Methods of addressing this issue are outlined 
in Section 3. Similarly, only low cell numbers can be 
printed to avoid the nozzle from clogging and to re-
duce shear stress on the cells[13]. However, once these 
issues are addressed, inkjet methods offer fast, cheap 
and high resolution bioprinting with the ability to 
change drop size and density, thereby the ability to 
create gradients. When this is coupled with multiple 
nozzles, it is clear why inkjet printing techniques are 
so attractive to tissue engineers[21,22].  
2.2 Laser-Induced Forward Transfer Bioprinting 
(LIFT) 
Laser-induced forward transfer (LIFT) technology 
uses pulses of laser focussed on a ‘ribbon’ upon which 
the biological material is layered as a solution. The 
pulse creates a high-pressure bubble which forces the 
biological material off the ribbon and onto a collector. 
The technology is not as popular as inkjet and micro-
extrusion for bioprinting but is increasingly being 
used23,24]. The component set-up for LIFT is entirely 
different to inkjet and microextrusion technologies 
and as such the printing resolution and speed is de-
pendent on factors including laser energy, material 
wettability and surface tension, the spacing between 
the ribbon and the substrate and material viscosity[25].  
The benefits of LIFT are that it is a nozzleless sys-
tem and so clogging of the print head is no longer an 
issue, a range of viscosities can be printed without 
causing a detrimental effect on cell viability[26] and 
high cell numbers can be printed[27]. These are all ad-
vantageous over conventional bioprinting systems. 
However, the complexity of LIFT is its biggest 
downfall. Individual ribbons are required for deposit-
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ing different bioinks which can be time-consuming 
and expensive when printing multiple materials or cell 
types. Furthermore, the ribbon coating method does 
not lend itself to distributing cells accurately and met-
al contaminants are present in the final printed con-
struct; as metal coating is used to create a laser energy 
absorbing layer on the ribbon.  
Even so, as the price for 3D printing is decreasing 
and LIFT technology is becoming more accessible, 
several researchers have used it to fabricate clinically 
relevant constructs, both acellular[28] and cellular [29,30]. 
As component parts are modified to suit bioprinting 
for the purpose of tissue engineering, the interest in 
this technology is likely to grow substantially.  
2.3 Microextrusion Bioprinting 
Microextrusion printing is one of the most popular 
and cheapest methods of non-biological printing[31]. 
The technique uses force to extrude material via a mi-
croextrusion head onto a stage, both of which can 
usually be controlled along the x, y and z axes[32]. For 
bioprinting, materials can be extruded mechanically or 
pneumatically[33]. Pneumatic systems are ideal for 
printing materials that have higher viscosities[34] as 
they are limited only by the system’s air-pressure ca-
pabilities and nozzle diameter. The mechanism is sim-
ple but delays caused by the compressed gas which 
controls material flow can affect the printing resolu-
tion. Mechanical motor-based microextruders are more 
complex and provide better spatial resolution but are 
limited by the forces they can generate and therefore 
struggle to extrude materials with high viscosities[35].  
The temperature of the stage and print head of a 
microextrusion system can be controlled, which al-
lows a range of materials to be printed[13]. Further-
more, as force is used to extrude the material, high cell 
densities can be printed, although, as with inkjet me-
thods, the forces generated can affect cell viability. As 
microextrusion uses higher forces than inkjet printing 
methods, the cell viability can be as low as 40%[36] or 
even lower if higher pressures are used. This impact 
on cell viability can be reduced by lowering the extru-
sion pressure and printing through nozzles with a large 
gauge size, although this in turn affects the printing 
resolution and speed. Nevertheless as microextrusion 
technology can print high cell densities and can be 
fitted with multiple extrusion heads, allowing for mul-
ti-material or multi-cell printing[37], it remains the 
most popular method for self-assembly cell printing; 
through which cells are deposited as spheroids without 
a secondary support material[38]. Microextrusion prin-
ting has already been used to produce aortic valves[39] 
and pharmokinetic[40] and disease[41] models. Further-
more, there is room for improvement as the technolo-
gy is capable of printing non-biological materials at 
high resolution.  
2.4 Stereolithography and Projection Pattern Bio-
printing 
Stereolithography is traditionally used to fabricate 
solid structures from photocurable polymer or resin 
using a laser and an x-y-z-controlled stage[42]. The 
technique is based on solid freeform fabrication with 
polymerised layers printed bottom-up, although top- 
down stereolithography approaches also exist. The 
printing resolution is dependent on laser energy and 
focus. Although traditionally the technique has been 
used to produce acellular scaffolds, researchers have 
incorporated photopolymerisable proteins and cell- 
guiding cues into the scaffolds using stereolithogra-
phy[43].  
Projection stereolithography, also known as digital 
micromirror device microfabrication, is a modification 
of the original system which uses micromirrors to 
create a reflective photomask for fabricating the scaf-
fold layer by layer[44]. Further advancements in the 
technology have led to the development of a more 
complex system which allows the entire 3D structure 
to be polymerised at the same time[45]. Such a system 
can dramatically reduce the printing speed. 
The main drawback with using traditional stereoli-
thography to print scaffolds is that it is not easy to 
incorporate cells into the structure and maintain via-
bility as it is being fabricated, unless the set-up is 
modified first[46]. Typically the scaffold is formed first 
and cells are seeded post-fabrication.  
3. Selecting Suitable Materials for 3D Bio-
printing 
The main challenge in engineering tissues is replicat-
ing the in vivo environment chemically, mechanically 
and morphologically. Therefore, the scaffold material 
on which the cells will be cultured is one of the most 
important initial choices to be made. The source of 
these materials may be natural or synthetic (Figure 1). 
Both types of materials have been used for tissue en-
gineering in equal measure[47−49]. Natural materials are 
biocompatible while synthetic materials can be mod-
ified easily and are therefore easier to handle during 
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Figure 1. Biodegradable polymers used for bioprinting applications. 
 
manufacture. However, natural materials often lack 
the mechanical integrity required whilst synthetic ma-
terials are often not biocompatible[50]. Some research-
ers have sought to overcome these issues by combin-
ing favourable elements from both categories to create 
hybrid materials[51,52]. Even so, not all of these mate-
rials are suited to 3D printing. While the high temper-
atures and solvents used in the initial 3D printing 
techniques are not employed for bioprinting, there are 
still certain criteria, which need to be met when se-
lecting suitable bioprinting materials. 
3.1 Printability 
It is important to be able to both deposit the material 
accurately and retain spatial resolution in order to 
control the overall scaffold geometry. Some bioprint-
ing techniques cannot print viscous materials (such as 
inkjet methods) while others shear-thin the material 
and therefore affect its formation (such as microextru-
sion). Temporal resolution is another aspect which 
needs to be addressed, as materials that take too long 
to ‘set’ will affect the spatial resolution of the scaffold, 
whilst materials that set too quickly will be in danger 
of blocking the nozzle. Other factors to consider are 
whether the cells or biomolecules will encounter shear 
stress or high temperatures during printing. Current 
cell-printing technologies report a high variation in 
cell viabilities; typically between 40% and 90%.  
3.2 Biocompatibility 
Original expectations of material biocompatibility 
centered on minimising inflammation and creating 
materials that would not produce cytotoxic side-eff-
ects. Today, however, biocompatibility can include the 
incorporation of biochemical functionality, i.e. growth 
factors or growth factor mimics, and nanoscale scaf-
fold morphology to improve and enhance the interac-
tion of cells with the scaffold, and therefore engi-
neered tissue with the in vivo environment[13]. It is 
vital to select a material which can be modified 
through the printing process such that there is the op-
tion of building complexity into the system.  
3.3 Degradation 
Degradation of a material into smaller chemical units 
due to material chemistry, oxidising agents, enzymes 
or ionising radiation and ultrasound occurs via two 
mechanisms: surface (materials loss layer by layer) or 
bulk (fragmentation of the whole material)[53]. Figure 
2 shows both mechanisms.  
The main indicators of degradation are reduction in 
sample mass, loss of mechanical strength and changes 
in chemical bonds and groups. Controlled degradation 
is vital as material loss and a reduction in mechanical 
integrity of the overall scaffold[54] can alter the cellular 
response to the material. For example, during bulk 
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Figure 2. Mechanisms of degradation: bulk (A) and surface (B) 
degradation. 
 
degradation scaffolds can become more porous, which 
in turn will have a profound effect on cell migration 
behaviour and nutrient uptake.  
When selecting a bioprintable material which has a 
suitable degradation profile, it is necessary to also 
consider whether the cells will contract the scaffold in 
any way and change its dimensions or whether the 
material’s swelling behaviour will be altered and the 
effect any by-products from degradation may have on 
surrounding tissue. A relatively inert and printable 
material or combination of materials that maintain the 
correct dimensions could still produce by-products 
that are toxic or not readily removed by the body[55] 
and therefore present new challenges in vivo.  
In order to assess the degradation behaviour of a 
material, factors such as chemical composition, ther-
mal properties, surface area to volume ratio and ste-
reochemistry must also be taken into consideration.  
3.4 Mechanical Strength and Structural Integrity 
As stated in Section 2.3, maintaining structural integr-
ity at the same rate as cell growth is highly challeng-
ing but necessary. Not only does it provide cells with a 
physical support, studies have also shown that a me-
chanical strength which matches in vivo conditions 
can strongly influence cell proliferation and differen-
tiation[56–58]. Several researchers have used a hybrid 
material approach to create a mechanically suitable 
environment[59,60]. However, the printability, from cha-
nges in viscosities and a mismatch in the most suitable 
printing technique for the materials, must be assessed 
and thus further adds to the complexity of the issue. 
These problems are not insurmountable and several 
researchers have created 3D printed hybrid scaffolds 
(see Section 4.3). 
4. Using Hydrogels for 3D Bioprinting 
Hydrogels are an ideal tissue engineering material 
which can be sourced naturally, created synthetically 
or used in combination with other materials[61–64]. Hy-
drogel networks are comprised of polymer or peptide 
chains. They have a high content of water, ideal for 
absorbing high levels of nutrients and oxygen[65], al-
lowing cells to migrate within the scaffold[66] and the 
waste to diffuse out[67].  
Synthesised materials, such as those based on po-
lyethylene glycol and polyacrylamide, offer more 
control over modification than naturally derived mate-
rials such as alginate, collagen, fibrin and hyaluronic 
acid[62,64]. 
4.1 Synthetic Materials 
Having control over gelation time and mechanical 
strength are two of the most important elements in 
hydrogel bioprinting. If the gelation time is too long, 
the spatial resolution is lost and layers cannot be 
printed with accuracy. To control the setting time the 
gelation mechanism can be manipulated by chemically 
modifying the material, introducing crosslinking 
agents or varying the polymer content[68]. Müller et 
al.[69] were able to control the printability of Pluronic, 
a block-copolymer, by mixing acrylated with unmodi-
fied Pluronic F127 and stabilising the structure 
through ultraviolet (UV) crosslinking while Barry et 
al.[70] used direct-write assembly and UV photopoly-
merisation to produce poly(acrylamide)-based gels for 
fibroblast culture. With any of the techniques the 
process of printing a new layer should not disrupt or 
dissolve the previously deposited material.  
Hydrogels as a whole have a high water content 
which is ideal for maintaining cell viability. However, 
the material provides low structural support[71]. By 
using chemical or physical crosslinking methods this 
can also be improved and therefore solve two major 
issues using one modification technique. Being able to 
control scaffold formation in this way would suggest 
that for bioprinting, synthetic materials, owing to their 
customisability, are superior to naturally-derived ma-
terials. However, cellular interactions and biocompa-
tibility is almost always better on natural materials 
than synthetic[72]. To improve the biocompatibility of 
synthetic materials, functional sequences, such as pep-
tide adhesion motifs, can be covalently attached to the 
material. The drawback of this approach is introducing 
even more complexity to an already modified system.  
3D bioprinting for tissue engineering: Stem cells in hydrogels 
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4.2 Natural Materials 
In contrast, natural materials, although inferior to 
synthetic hydrogels in terms of controlling gelation 
kinetics and mechanical strength, are able to chemi-
cally and physically mimic native extracellular matrix 
(ECM). Collagen is the most abundant component of 
ECM[73]. It is widely used in tissue engineering appli-
cations and contains cell-guiding chemical cues, such 
as the cell adhesion peptide sequence arginine-glycine- 
aspartic acid (RGD)[74]. However, although it is wide-
ly used as a bioprinting material, collagen is an un-
likely gold-standard candidate as it contracts and does 
not retain its original shape.  
Hyaluronic acid (HA), is also a naturally derived 
material which does retain its shape and is already 
used clinically[75]. HA forms very soft gels but can be 
modified and crosslinked using a variety of methods 
including the UV method described in Section 4.1[76] 
and thiol-modified HA using gold nanoparticles[77] to 
increase its stiffness. Similarly, fibrin is already used 
in surgery as a haemostatic agent and sealant[78,79]. The 
added complexity with fibrin is that it crosslinks 
through the addition of thrombin. However, it can 
produce mechanically stable hydrogels and has been 
blended with other gels for bioprinting purposes[80].  
Some natural gels are difficult to print, not because 
they form soft gels as described in the earlier exam-
ples, but because their gelation properties are unde-
sirable. Gelatin is one such material. It forms a gel 
easily by temperature control but has a melting tem-
perature of 30–35°C[81], which is below the standard 
physiological temperature of 37°C. Similarly, alginate 
produces gels easily through cation crosslinking, but 
unless it is modified with motifs that can guide cells to 
adhere, proliferate and differentiate, it is relatively 
inert[82]. 
4.3 Hybrid Materials 
An alternative approach to producing scaffolds with 
desirable properties is to create a hybrid. A study on 
methacrylated hyaluronic acid combined with metha-
crylated gelatin showed that not only could cell viabil-
ity be maintained but by varying the concentrations of 
the two materials, the stiffness and viscosity of the 
hybrid could be controlled[83]. Other researchers have 
used a similar approach to bioprint scaffolds for a 
range of uses, including cartilage engineering[84] and 
to tune material properties for a range of scaffolds[85].  
The main issue in using this approach is matching 
the printable properties of the separate materials or 
selecting a bioprinting technique which would allow 
both materials to be printed simultaneously under dif-
ferent conditions. Although the latter adds another 
level of complexity to printing 3D biocompatible 
scaffolds, it is a branch of bioprinting that is currently 
being explored[86].  
5. Cell Encapsulation in Hydrogels for Printa-
ble Bioinks 
The choice of cells for 3D bioprinting is often based 
on the type of tissue being created. However, as tis-
sues and organs are composed of multiple cell types 
which have a range of specific functions, it is likely 
that the bioprinting requirement will be for a mixture 
of cells. Current methods predominantly involve 
printing individual cell types in specific patterns, de-
signed to mimic native tissue cell distribution[87]. Al-
though cells have been printed in single drops, with 
each drop containing one or two cells[88], it is currently 
not possible to print individual cells reliably. This is 
not an issue as long as large cell agglomerates (clus-
ters of cells large enough to cause cell death at the 
centre of the cell mass) can be avoided and cell-to-cell 
contact can be maintained. The size of these agglo-
merates will depend on the type of cells used and the 
ease with which nutrient and waste exchange can oc-
cur at the centre of the mass. 
For a more efficient system, resembling a native 3D 
environment, a material-cell composite ink would be 
more suitable. The ability to encapsulate cells within 
the material as it is being printed allows researchers to 
create a more tissue-like environment compared with 
creating a 2D construct first onto which cells are then 
seeded[89]. With hydrogels this has been attempted 
with some success[90], creating cell-laden constructs 
that contain microvascular networks[91] and are able to 
integrate well with native tissue[22]. Combining cells 
with hydrogels is a delicate balance of maintaining 
high cell viability whilst ensuring that there are not 
too many cells in the gel to cause hyperplasia or 
apoptosis, either by optimising the number of cells 
added at the loading stage of the process or by con-
trolling the rate of cell proliferation post-printing[13].  
When using hydrogels with cells, there are a num-
ber of factors which could cause cell death. One of the 
most obvious causes is the method selected for gela-
tion. During crosslinking or temperature-based gela-
tion the cell viability could be substantially affected[92]. 
The introduction of cytotoxic crosslinking agents 
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should be avoided and as cells are only able to survive 
in a narrow temperature range, the list of gel candi-
dates is substantially reduced. However, by combining 
materials, the list of printable gels could once again be 
expanded.  
Furthermore, the time required for gelation is of 
importance. The longer it takes for the material to be 
printed and form the structure, the more likely the 
layers printed at the start of the process will lose via-
bility, thus limiting the use of the construct. Other 
factors include the introduction of stress on cells thr-
ough changes in the viscosity of the gel. While control 
of viscosity would make the gel more printable, slight 
changes could lead to low cell viability rates. Stress 
could also be introduced by methods of extruding the 
bioink[36] and changes in temperature during the prin-
ting process, although the latter is dependent on how 
long high temperatures are maintained. In their study, 
Cui et al.[16] reported a rise in temperature during 
printing from 22°C to 46°C. However, as the drops 
produced cooled within seconds, no significant apop-
tosis was observed. 
6. Using Stem Cell for 3D Bioprinting 
The ideal cell type for bioprinting is dependent on the 
accessibility and availability of the cells, the self-ren-
ewal and expansion capacity, differentiation profile 
and cellular tumorigenicity as well as viability fol-
lowing encapsulation and printing. Stem cells are a 
particularly attractive cell type as they are pluripotent 
and able to differentiate into other cell types upon ex-
posure to the correct physical and chemical guidance 
cues[93]. Within the human body, there are a number of 
viable sources of stem cells, such as the bone marrow, 
periosteum and adipose tissue[94–96].  
6.1 Stem Cells Selection  
Stem cell differentiation can be guided through the 
incorporation of tissue-specific chemical signals in the 
scaffold, although some researchers suggest that this 
may not be necessary to promote differentiation and 
subsequent tissue regeneration[97]. While the advan-
tages of using pluripotent cells in bioprinting are clear, 
there are ethical considerations which must be taken 
into account when using stem cells. Furthermore, the 
generation of pluripotent stem cells from adult cells 
(induced pluripotent stem cells, iPSC) pose the risk of 
tumorigenicity which must also be considered[98]. Eth-
ical issues aside, there are three main categories of 
stem cells which can be considered for 3D bioprinting: 
embryonic, somatic and iPSC.  
6.1.1 Embryonic Stem Cells (ESCs)  
With the ability to form any cell type and indefinite 
self-renewal[99], embryonic stem cells (ESCs) are the 
ideal cell type for tissue engineering. One of the chal-
lenges in using ESCs for regenerating or repairing 
tissue is identifying the conditions needed to drive the 
cells towards a specific lineage. As cell differentiation 
is influenced by both chemical and physical cues, the 
identification of ideal culture conditions adds another 
level of complexity to an already difficult task.  
The biggest drawback of using ESCs is that they 
are derived from a blastocyst. In some countries, 
ESCs research is prohibited or severely restricted due 
to the ethical issues this raises. Furthermore, where 
research in the field is allowed, the number of cells 
derived from an embryonic source is low and, unless 
expanded significantly in vitro, is unlikely to meet 
clinical demand.  
6.1.2 Adult Stem Cells 
Adult stem cells cover any postnatal somatic cell that 
is undifferentiated and can self-renew[100]. These cells 
can be derived from a number of sources including 
brain, liver and bone marrow[101]. Mesenchymal stem 
cells (MSCs) are readily available from bone marrow, 
adipose tissue, amniotic fluid, the synovium and pe-
riosteum and are known to be less tumorigenic than 
their embryonic or fetal counterparts[98]. MSCs are 
non-haematopoietic, are relatively straightforward to 
obtain via bone marrow harvesting methods[102] and 
interact well with a range of materials that may be 
used for cellular encapsulation to produce viable bio-
inks. Table 1 features the types of adult MSCs which 
have been used for bioprinting applications.  
Although MSCs can be harvested from the patient’s 
own tissue, and therefore reduce the risk of rejection, 
only 0.001%–0.01% of total nucleated cells in bone 
marrow are MSCs[102]. A possible alternative source 
which could be used is adipose derived MSCs 
(ADMSCs). Adipose tissue is abundant and many re-
searchers have used ADMSCs successfully towards 
tissue engineering[94,103,104].  
6.1.3 Induced Pluripotent Stem Cells (iPSC) 
The discovery that stem cells can be generated directly 
from adult cells by the introduction of four transcription 
factors has revolutionised biomedical research[105–108]. 
By using the patient’s own cells, the ethical issues 
related to stem cell research and the concern sur-
rounding tissue rejection can be avoided. Furthermore, 
as the iPSCs can be derived from any somatic cell, the 
3D bioprinting for tissue engineering: Stem cells in hydrogels 
 
8 International Journal of Bioprinting (2016)–Volume 1, Issue 1 
 
Table 1. Examples of human mesenchymal stem cells used in bioprinting and their performance 
No. Human Cell Type Scaffold Materials Regenerated Tissue Bioprinting Technologies References 
1 Amniotic-derived mes-
enchymal stem cells 
Fibrin-collagen Hydrogel Skin Inkjet Skardal et al. 2012[21] 
(a) Evidence of re-epithelialisation on skin wound in mice with an increase in microvessel density and capillary diameter over 14 days. 
However, cells did not fully integrate with native tissue. 
2 Adipose-derived mes-
enchymal stem cells 
Alginate Adipose Laser-assisted (a) Gruene et al. 2011[119] 
(a) Adipogenic lineage pathway maintained for 10 days with expression of adipogenic markers similar to those expressed in native adipose 
tissue. 
3 Bone marrow-derived 
mesenchymal stem cells 
(a) acrylated peptides and acrylated 
poly(ethylene glycol) 
(b) poly L-lysine coated carbon 
nanotubes and acetylated collagen  
Bone and Cartilage Inkjet (a) Gao et al. 2015[120] 
(b) Holmes and Zhang 
2013[121] 
(a) High cell viability (87.9 ± 5.3%) and good differentiation, evidenced by mineral and cartilage matrix deposition. 
(b) Biomimetic poly L-lysine coated carbon nanotubes and acetylated collagen can induce proliferation of MSCs. 
 
yield is high.  
However, as a relatively recent discovery, there is 
still a lot of research to be done on how the cells be-
have long term. Furthermore, genetic manipulation of 
cells poses a risk of tumorigenicity[98], introducing 
new problems in their clinical use. For this reason, 
some researchers have sought to find alternative 
routes for generating iPSCs, for example via protein 
reprogramming[109].  
6.2 Stem Cell Bioprinting 
When selecting cells for bioprinting, an important 
factor to consider is the robustness of the cells. Many 
of the 3D bioprinting technologies outlined in Section 
2 can affect cell viability, some of which are discussed 
in Section 5, and with a limited supply of stem cells, it 
is essential that this is taken into consideration. While 
selecting the appropriate bioprinting technique, it is 
important to ensure that the stem cells retain their plu-
ripotency. If the printing method affects the differen-
tiation potential, primarily through creating a microen-
ironment to which the stem cells are sensitive[110–112], 
then a complex scaffold, irrespective of whether it 
contains cell-guiding functional motifs, is unlikely to 
produce the desired tissue. Using laser-based printing, 
Gruene et al.[113] showed that this is possible. Fur-
thermore, early consideration of the interaction be-
tween stem cells, the encapsulating material and other 
cell types used during the bioprinting process could 
also increase overall viability and help maintain plu-
ripotency[114–116]. 
As stem cells are sensitive to topography, the scaf-
fold design could strongly influence cell morphology, 
proliferation and differentiation without the need for 
additional biological cues[117,118]. Eliminating the addi-
tion of growth factors or growth factor-like cues, to 
reduce bioink complexity, could help improve bio-
printing resolution and the overall quality of the 
product. With the right combination of stem cells, bi-
oprinting technology and scaffold materials, engi-
neering a functional tissue suitable for clinical appli-
cations becomes a very real possibility.  
7. Future Directions  
With the progression in complexity of bioprinted 
structures, it is clear that the future of clinically rele-
vant 3D printed materials lies in replicating complex 
and heterogeneous tissues. In this review we have de-
scribed how technological advancement has occurred 
in parallel to hybrid material development. Bioprint-
ing is no longer confined to a process for combining 
one cell type with one material; the emphasis today is 
to use a variety of material types to create bespoke 
scaffolds onto which chemical cues can be tethered 
and multiple cell types can be printed with precision.  
Popularity in the use of this technology has led to 
cheaper systems being made available and therefore 
more accessible. However, the speed at which the 
scaffolds are produced is still an area of exploration. 
This progress is necessary, not only to maintain high 
cell viability rates but also to scale up the process and 
fabricate enough scaffolds to meet clinical demands. 
Kolesky et al.[91] estimate that to print an adult human 
liver using a single nozzle with a 200 µm diameter, it 
would take 3 days. However, by switching to a 
64-nozzle system under the same conditions this could 
be reduced to 1 hour. Such a difference in production 
speeds could result in scaffolds being produced to 
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meet individual needs quickly whilst reducing the sur-
gical demand for bespoke solutions.  
Material compatibility with such advanced systems 
must also be assessed. A physiologically relevant sca-
ffold must be able to support and guide cell growth 
and differentiation both chemically and physically. As 
well as creating complex blends of bioinks, this would 
require heterogeneous material fabrication and preci-
sion-printing to create organized gradients or complex 
patterns of cells and functional motifs which mimic 
native ECM more closely. One approach currently 
being explored to meet these requirements is the use 
of smart materials, i.e., materials that are able to 
change their shape, mechanical strength and permea-
bility in response to external or physiological stimu-
li[117]. Smart hydrogels can respond to changes in 
pH[122], temperature[123] and electric and magnetic 
fields[124,125]. These materials are particularly attractive 
as the scaffold could mould itself as the cells mature.  
An alternative approach is to print decellularised 
ECM directly to provide the structural and chemical 
cues the cells require. It is believed by some research-
ers that no matter how complex the hydrogel-based 
scaffolds become, decellularised ECM is still the 
closest representation of an in vivo environment[126] 
and therefore the future of bioprinting tissues. The 
downside with this method is harvesting the ECM first 
but if tissue-specific ECM can be derived with ease, 
then this method may help resolve some of the cell 
functionality issues currently experienced when using 
other, more conventional scaffolds. 
Through the various examples cited in this review, 
it is clear that bioprinting itself has been successfully 
used to maintain cell viability and incorporate 
cell-guiding cues into complex scaffold materials. The 
main challenge facing researchers in this field today is 
fine-tuning the technique to mirror native tissue com-
plexity. The goal in tissue engineering is always to 
improve the patient’s quality of life and by creating 
bespoke materials that are able to regenerate or guide 
tissue development in a cheap and fast way, 3D bio-
printing has become a powerful and highly flexible 
tool for achieving this. Furthermore, as knowledge on 
technologies and materials advances, it is entirely 
plausible that in the future in situ bioprinting systems 
could be developed to both scan the patient’s wound 
site and print the cell-laden scaffold directly into the 
wound, all without leaving the operating theatre. Sig-
nificant progress in this area has already been made 
towards skin[21] and cartilage repair[22].  
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